Davita Healthcare Partners Inc (DVA)

$140.53 -2.88 (-2.01%)
Market Cap 10.76B
Revenue (ttm) 12.82B
Net Income (ttm) 936.34M
EPS (ttm) N/A
PE Ratio 15.23
Forward PE 13.34
Profit Margin 7.31%
Debt to Equity Ratio -1,501.73
Volume 672,926
Avg Vol 821,240
Day's Range N/A - N/A
Shares Out 75.50M
Stochastic %K 49%
Beta 1.11
Analysts Sell
Price Target $162.28

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720-631-2100
Address:
2000 16th Street, Denver, United States
Noname2022
Noname2022 Jul. 11 at 3:40 AM
$CRMD $DVA
4 · Reply
Noname2022
Noname2022 Jul. 10 at 1:16 AM
$CRMD $DVA
1 · Reply
theoptionsplug
theoptionsplug Jul. 4 at 6:54 PM
$DVA DaVita Daily Chart 🏥 - On May 27th, Berkshire $BRK.A / $BRK.B acquired a 44.8% stake in the company (a $4,818,034,885 position) - Looks good to dabble on here as price pulls back to its 50 DMA. I like shares over trading options on it...
1 · Reply
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
IntensiveCareUnit
IntensiveCareUnit Jun. 23 at 6:26 PM
$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.
1 · Reply
Ryant19
Ryant19 Jun. 23 at 3:26 PM
$CRMD Too bad $DVA is in bed with $ICUI. Turning a blind eye to patient safety due to back room deals
1 · Reply
Thewonderyears
Thewonderyears Jun. 16 at 8:56 AM
$DVA Government Contract Update: $206M payment to DAVITA INC
0 · Reply
DonCorleone77
DonCorleone77 May. 30 at 8:05 PM
$DVA DaVita 'applauds' CMMI decision to extend Kidney Care Choices Model DaVita issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation related to its Kidney Care Choices Model. Misha Palecek, Chief Transformation Officer for DaVita, said: "As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."
0 · Reply
Mallingan
Mallingan May. 29 at 12:38 PM
$DVA
0 · Reply
AlertsAndNews
AlertsAndNews May. 28 at 2:53 AM
$DVA $BRK.A $BRK.B DaVita Buffett selling some. Warren E. Buffett (10%+ owner) sells 200,000 shares at an average price of $138.85. Still has 33M+ shares.
0 · Reply
Latest News on DVA
20 stocks primed for rapid growth while trading at half of Nvidia's valuation

Jun 2, 2025, 12:15 PM EDT - 6 weeks ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 30, 2025, 2:35 PM EDT - 6 weeks ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

DaVita: International Expansion And Buybacks Will Boost Returns

May 27, 2025, 11:30 AM EDT - 7 weeks ago

DaVita: International Expansion And Buybacks Will Boost Returns

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 4:42 PM EDT - 2 months ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 9:05 AM EDT - 2 months ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 2 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:41 PM EDT - 2 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 5:37 PM EDT - 2 months ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 2 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 2 months ago

DaVita Inc. 1st Quarter 2025 Results

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 2 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 3 months ago

DaVita Says Ransomware Attack Affecting Some Operations

Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 3 months ago

Dialysis firm DaVita hit by ransomware attack

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 3 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Mar 6, 2025, 10:00 AM EST - 4 months ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 27, 2025, 9:00 AM EST - 4 months ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 5 months ago

Berkshire Hathaway sells another 750,000 DaVita shares

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 1:01 PM EST - 5 months ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 14, 2025, 8:16 AM EST - 5 months ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:19 PM EST - 5 months ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 5 months ago

Berkshire sells some DaVita shares, cuts stake to 45%

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 5 months ago

DaVita forecasts 2025 profit below estimates, shares plummet

DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 5 months ago

DaVita Inc. 4th Quarter 2024 Results

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 30, 2025, 11:55 AM EST - 5 months ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

Jan 28, 2025, 2:39 PM EST - 6 months ago

Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

CI CVS HCA UHS

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

Jan 15, 2025, 9:05 AM EST - 6 months ago

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

Jan 9, 2025, 11:00 AM EST - 6 months ago

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 14, 2024, 2:19 PM EST - 8 months ago

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

Nov 12, 2024, 9:05 AM EST - 8 months ago

DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

Nov 8, 2024, 4:33 PM EST - 8 months ago

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 9:27 PM EDT - 9 months ago

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

DaVita misses third-quarter profit estimates on higher costs

Oct 29, 2024, 4:23 PM EDT - 9 months ago

DaVita misses third-quarter profit estimates on higher costs

DaVita Inc. 3rd Quarter 2024 Results

Oct 29, 2024, 4:05 PM EDT - 9 months ago

DaVita Inc. 3rd Quarter 2024 Results

DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program

Oct 28, 2024, 11:05 AM EDT - 9 months ago

DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program

DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024

Oct 23, 2024, 10:00 AM EDT - 9 months ago

DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024

DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program

Oct 22, 2024, 8:00 AM EDT - 9 months ago

DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program

DaVita Appoints Jessica Hergenreter as Chief People Officer

Oct 17, 2024, 1:00 PM EDT - 9 months ago

DaVita Appoints Jessica Hergenreter as Chief People Officer

DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton

Oct 11, 2024, 3:58 PM EDT - 9 months ago

DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

Oct 9, 2024, 1:47 PM EDT - 9 months ago

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton

Oct 8, 2024, 1:38 PM EDT - 10 months ago

DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton

DaVita Accelerates Commitment to Community Health with Nationwide Tour

Sep 17, 2024, 9:00 AM EDT - 10 months ago

DaVita Accelerates Commitment to Community Health with Nationwide Tour

DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

Sep 13, 2024, 8:00 AM EDT - 10 months ago

DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

Aug 30, 2024, 8:00 AM EDT - 11 months ago

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

DUK JNJ

DaVita: Scope For Valuation Upsides With Strengthening Economics (Rating Upgrade)

Aug 20, 2024, 11:12 AM EDT - 11 months ago

DaVita: Scope For Valuation Upsides With Strengthening Economics (Rating Upgrade)

DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering

Aug 8, 2024, 5:34 PM EDT - 1 year ago

DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering

DaVita Inc. Announces Offering of $1.0 Billion Senior Notes

Aug 8, 2024, 9:16 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $1.0 Billion Senior Notes

DaVita Inc. 2nd Quarter 2024 Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

DaVita Inc. 2nd Quarter 2024 Results

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

Aug 6, 2024, 3:20 AM EDT - 1 year ago

The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data

AAPL ABNB AMZN BAX CAT CSX DIS

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

Jul 18, 2024, 2:00 PM EDT - 1 year ago

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research

Jul 16, 2024, 10:20 AM EDT - 1 year ago

Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research

MDT

Noname2022
Noname2022 Jul. 11 at 3:40 AM
$CRMD $DVA
4 · Reply
Noname2022
Noname2022 Jul. 10 at 1:16 AM
$CRMD $DVA
1 · Reply
theoptionsplug
theoptionsplug Jul. 4 at 6:54 PM
$DVA DaVita Daily Chart 🏥 - On May 27th, Berkshire $BRK.A / $BRK.B acquired a 44.8% stake in the company (a $4,818,034,885 position) - Looks good to dabble on here as price pulls back to its 50 DMA. I like shares over trading options on it...
1 · Reply
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
IntensiveCareUnit
IntensiveCareUnit Jun. 23 at 6:26 PM
$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.
1 · Reply
Ryant19
Ryant19 Jun. 23 at 3:26 PM
$CRMD Too bad $DVA is in bed with $ICUI. Turning a blind eye to patient safety due to back room deals
1 · Reply
Thewonderyears
Thewonderyears Jun. 16 at 8:56 AM
$DVA Government Contract Update: $206M payment to DAVITA INC
0 · Reply
DonCorleone77
DonCorleone77 May. 30 at 8:05 PM
$DVA DaVita 'applauds' CMMI decision to extend Kidney Care Choices Model DaVita issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation related to its Kidney Care Choices Model. Misha Palecek, Chief Transformation Officer for DaVita, said: "As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."
0 · Reply
Mallingan
Mallingan May. 29 at 12:38 PM
$DVA
0 · Reply
AlertsAndNews
AlertsAndNews May. 28 at 2:53 AM
$DVA $BRK.A $BRK.B DaVita Buffett selling some. Warren E. Buffett (10%+ owner) sells 200,000 shares at an average price of $138.85. Still has 33M+ shares.
0 · Reply
Mallingan
Mallingan May. 26 at 10:41 AM
$DVA https://www.ibtimes.co.uk/warren-buffett-sells-168m-davita-shares-one-day-before-dialysis-provider-hit-lawsuit-1733814
0 · Reply
Mallingan
Mallingan May. 24 at 12:29 PM
$DVA https://www.reuters.com/legal/government/dialysis-giants-davita-fresenius-medical-sued-by-employee-benefits-plan-2025-05-12/
0 · Reply
FuckThisTrade
FuckThisTrade May. 22 at 7:56 PM
$DVA is undervalued. Intrinsic Value Estimates: Alpha Spread calculates DaVita’s intrinsic value at approximately $245.17, suggesting the stock is undervalued by about 43% compared to its current market price of $138.74 .  • Discounted Cash Flow (DCF) Analysis: Simply Wall St estimates a fair value of $271.71 per share, indicating the stock is trading at a 48% discount .  • Price-to-Earnings (P/E) Ratio: DaVita’s current P/E ratio is 14.35, which is below its 12-month average of 15.68 and significantly lower than the healthcare industry average of 24.17 . 
0 · Reply
bullishbaer
bullishbaer May. 20 at 9:38 PM
$DVA I wanted to share a quick update on a significant move we’ve made that reflects the strength and strategic direction of our company. We recently up-sized and priced our previously announced private offering increasing it to $1.75 billion in aggregate principal amount of senior notes due 2032. The notes will carry a 5.000% annual interest rate, paid semi-annually. The strong investor interest that allowed us to up-size this offering speaks volumes about confidence in our long-term vision. Proceeds will primarily go toward refinancing our 4.625% senior notes due 2030 and supporting overall corporate initiatives. From inside the company, I can tell you there’s a lot of energy around the thoughtful way we're managing our capital structure to support future growth and operational resilience.
0 · Reply
CHItraders
CHItraders May. 20 at 8:44 PM
$DVA DaVita Announces Upsize And Pricing Of Its Previously Announced Private Offering Of Its 6.750% Senior Notes Due 2033 From $750M To $1B
0 · Reply
JarvisFlow
JarvisFlow May. 19 at 1:15 PM
Truist Securities has adjusted their stance on DaVita ( $DVA ), setting the rating to Hold with a target price of 170 → 164.
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 May. 13 at 9:49 PM
$DVA LMAO They won’t reveal how bad the business is doing. They will keep buying its own stock, spending all free cash and then some. This will end really badly. JMO
1 · Reply
Bazzzigar
Bazzzigar May. 13 at 9:42 PM
$DVA Sold...Moved to UNH
0 · Reply
ballzdeep12
ballzdeep12 May. 13 at 3:01 PM
$DVA easy money. This shit always goes back to above 140
0 · Reply
Gecko1987
Gecko1987 May. 13 at 2:08 PM
$DVA curious if anyone listened to this advice?
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 May. 13 at 1:38 PM
$DVA Tanking as expected.
1 · Reply
profit_guru
profit_guru May. 13 at 1:28 PM
$DVA - they have consistent share buybacks…must be trading above 160…imo
0 · Reply